{
  "Q0": "Whole Exome Sequencing (WES) with trio testing",
  "Q1": "Yes",
  "Q2": "Yes",
  "Q3": "Yes",
  "Q4": "Yes",
  "Q4.1": "Yes",
  "Q4.2": "ACMG",
  "Q5": "Yes",
  "Q6": "No",
  "Q7": "Yes",
  "Q8": "No",
  "Q9": "Yes",
  "Q9.1": "Yes",
  "Q10": "No",
  "Q10.1": "Diagnostic",
  "Q11": "Yes",
  "Q12": "Yes",
  "Q13": "Not specified",
  "Q14": "Yes",
  "Q14.1": "81415 (for proband) and 81416 (for parents as part of trio)",
  "Q15": "No",
  "Q16": "Yes",
  "Q17": "The policy does not specify detailed claim submission steps, but the test should be ordered by a clinician with expertise in clinical genetics, and genetic counseling should be provided. Documentation should include the previous negative chromosomal microarray test results, clinical presentation of neurodevelopmental delay and seizures, family history of neurodevelopmental disorders (brother with autism spectrum disorder), and justification for how the test results may change management and clinical outcome for the patient.",
  "match": false
}